EE568 Challenges to Hepatitis C Treatment Access in Vietnam: A Micro-Costing Study

Chronic hepatitis C virus infection remains a significant public health problem with an estimated of 58 million people globally infected. Direct-Acting Antivirals (DAAs) have revolutionized Hepatitis C treatment and can achieve high cure rates (>90%). However, the costs of DAAs in Vietnam remain a potential barrier for treatment. Our study aims to investigate the costs of DAAs treatment for Hepatitis C in Vietnam in order to provide suggestions to increase the coverage of DAAs treatment.